CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
Single point canedevice
Likely dose
Single point cane for gait evaluationAI-extracted
Key inclusion· 6
  • ✓Age 45-85 years old
  • ✓Able to walk 30 feet without postural sway and stand unaided
  • ✓Knee pain on movement with WOMAC pain subscale >35 mm
  • ✓Documented osteoarthritis on clinical and radiographic criteria
Key exclusion· 10
  • ✕Knee surgery or arthroscopy within past 6 months
  • ✕Severe obesity with weight >300 lbs
  • ✕Upper body weakness
  • ✕Lower extremity injury or amputation

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00223795
NCT00223795N/ACompleted
CompareCT.gov

Walking Aids in the Management of Obesity-Related Knee Osteoarthritis

VA Office of Research and Development·interventional·Posted Sep 22, 2005·Updated Nov 1, 2017

In Brief

A clinical study evaluating Single point cane for Obesity and Osteoarthritis. Completed, enrolled 53 participants across 1 site.

Detailed Summary

The purpose of this study is to assess whether the single point cane will relieve pain and disability in overweight or obese people with knee OA through altered joint biomechanics and what factors influence acceptance of cane use.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Osteoarthritis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 22, 2005
Enrollment StartJul 1, 2006
Primary CompletionSep 1, 2008
Study CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 20.8 years ago

Interventions

Single point canedevice

Participants with symptomatic knee osteoarthritis will undergo gait evaluation with and without a single point cane.